Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

PEAR Therapeutics
745 Atlantic Ave.
Boston, MA 02111
Phone: 646-932-2774
https://peartherapeutics.com/

PEAR Therapeutics is the leader in FDA-cleared prescription digital therapeutics. The company's approach is to integrate clinically-validated software applications with previously approved pharmaceuticals and treatment paradigms to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. PEAR's lead product, reSET, is an FDA-cleared 12-week interval prescription therapeutic for Substance Use Disorder (SUD) to be used as an adjunct to standard, outpatient treatment. PEAR's product development pipeline includes reSET-O™ for opioid use disorder (OUD) and additional prescription digital therapeutics in schizophrenia (THRIVE™), combat post-traumatic stress disorder (reCALL™), general anxiety disorder (reVIVE™), pain, major depressive order, and insomnia, for which PEAR intends to obtain FDA clearance.

Key Contact
Name
Corey McCann
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
01/02/18 $50,000,000 Series B 5AM Ventures
Arboretum Ventures
Bridge Builders Collaborative
EDBI
Jazz Venture Partners
Novartis Venture Funds
Temasek
undisclosed
01/04/19 $64,000,000 Series C 5AM Ventures
Arboretum Ventures
Blue Water Life Science Fund
Bridge Builders Collaborative
EDBI
Jazz Venture Partners
Novartis Venture Funds
Temasek
Trustbridge Partners
undisclosed
12/10/20 $80,000,000 Series D 5AM Ventures
Arboretum Ventures
CrimsoNox Capital
EDBI
Forth Management
Jazz Venture Partners
Novartis
Pilot House Ventures
Sarissa Capital
Shanda Group
SoftBank Vision Fund 2
Temasek
undisclosed